When the Centers for Medicare & Medicaid Services(CMS) released its January 26 Medicare Advantage Proposed Rule 2027, most attention went straight to the rates. That reaction was predictable. Payment updates influence bids, margins, and near-term strategy across organizations participating in Medicare Advantage.

Medicare Advantage Proposed Rule 2027: The Headline Number Isn’t the Whole Story

Beneath the rate impact sits a quieter signal — one that speaks less to percentage changes and more to operating discipline. The Medicare Advantage Proposed Rule 2027 reinforces expectations around risk adjustment documentation integrity and encounter-linked support for diagnoses- a signal that CMS risk adjustment requirements are becoming more explicit and less forgiving. However, it is more than that.

Over the past decade, Medicare Advantage organizations built distinct capabilities around risk adjustment strategy and quality performance. Risk teams focused on documentation accuracy, chart review programs, and RAF optimization. Quality teams concentrated on Star measures, medication adherence, preventive screenings, and gap closure campaigns. Each function developed its own workflows, dashboards, and leadership cadence. The separation made sense. Incentives were structured that way.

Risk accuracy drove revenue integrity. Medicare Advantage Star ratings influenced bonuses and public ratings. Both mattered. And both could be optimized largely within their own domains. That boundary is now blurring.

Medicare Advantage Risk Adjustment and Star Ratings Can No Longer Operate Separately

By strengthening expectations for longitudinal documentation support, CMS is narrowing the space between reported risk and demonstrated care. A diagnosis that drives payment must now be supported not only at the point of capture, but across time — in treatment patterns, monitoring, and utilization.

Risk adjustment documentation cannot drift from clinical reality without consequence — and those consequences extend beyond audit exposure.

Consider a member documented with significant chronic burden. That profile implies ongoing management: medication adherence, consistent monitoring, specialist engagement, coordinated care. When those patterns do not materialize, the gap surfaces in more than one place. It weakens defensibility.It also weakens performance.

Inconsistent follow-through on chronic conditions affects adherence measures. Gaps in monitoring influence outcome metrics. Risk profiles that do not reconcile with care delivery often correlate with avoidable utilization and unstable results. The same inconsistencies that raise RADV audit concerns tend to surface as volatility in Medicare Advantage star ratings. Unsupported risk does not simply invite clawbacks. It destabilizes predictability.

For years, organizations could pursue Risk Adjustment Factor (RAF) lift and Star improvement as parallel strategies. Gains in one area did not necessarily require structural integration with the other. Under the direction implied by the January proposal — and likely reinforced as the Medicare Advantage Final Rule takes shape — that independence feels increasingly fragile.

Risk credibility and quality performance are not separate levers. They are reflections of the same underlying clinical story. From Functional Excellence to Enterprise Coherence.

When that story is coherent — when documented risk, care delivery, and outcomes align — revenue becomes more stable and performance more durable. When it is not, pressure accumulates across the system: RAF variability, Star instability, denials, audit scrutiny.

What appears on the surface as a payment update begins to look like an operating mandate.

The January proposal may be remembered for rate compression. Its more lasting effect may be the rising CMS compliance expectations around the quiet integration it accelerates — binding documentation integrity to care delivery in ways that make functional silos harder to sustain.

Preparing for the Medicare Advantage Final Rule 2027

As organizations begin planning for the next cycle, including forward-looking implications of the Medicare Advantage Proposed Rule 2027 and the expected Medicare Advantage Final Rule, the strategic question becomes clearer: are risk documentation and quality performance operating from the same clinical truth?

The organizations that navigate the next cycle most effectively will not be those that simply optimize coding or intensify quality campaigns. They will be those that ensure risk and care tell the same story — consistently, longitudinally, and defensibly.

In that environment, coherence is no longer optional.
It is operational stability.

Recalibrate your risk adjustment strategy to keep up with the changing tides. Contact us for a consultation.

Frequently Asked Questions

Q1. When was the Medicare Advantage Proposed Rule 2027 released?

The Medicare Advantage Proposed Rule 2027 was released by the Centers for Medicare & Medicaid Services (CMS) on January 26, 2026 as part of the agency’s annual update to Medicare Advantage and Part D program policies. Each year, CMS publishes a proposed rule outlining potential changes to payment policies, risk adjustment models, quality programs, and operational requirements for Medicare Advantage plans.

The full proposed rule can be accessed on the CMS website: https://www.cms.gov/medicareadvantage

Q2. Where can I read the full Medicare Advantage Proposed Rule 2027?

The full Medicare Advantage Proposed Rule 2027 is published by the Centers for Medicare & Medicaid Services and can be accessed on the CMS website. The document outlines proposed updates to payment policies, risk adjustment methodology, quality programs, and operational requirements for Medicare Advantage and Part D plans.

Q3. When will the Medicare Advantage Final Rule for 2027 be released?

After reviewing public comments on the Medicare Advantage Proposed Rule, CMS typically publishes the Medicare Advantage Final Rule in April of the same year.

The final rule confirms which policy updates will ultimately take effect for the upcoming plan year and may include revisions based on industry feedback. For Medicare Advantage organizations, the period between the proposed and final rule is an important window for assessing operational, financial, and compliance implications.

Q4. What happens between the Medicare Advantage Proposed Rule and the Final Rule?

After releasing the Medicare Advantage Proposed Rule, CMS opens a public comment period during which health plans, provider organizations, and industry stakeholders can submit feedback. CMS reviews these comments before publishing the Medicare Advantage Final Rule, typically in April, which confirms the policies that will ultimately take effect.

Q5. What does the Medicare Advantage Proposed Rule 2027 include?

The Medicare Advantage Proposed Rule 2027 outlines several policy areas that can influence plan performance and operational strategy. These typically include:

  • Updates to Medicare Advantage payment policies
  • Changes affecting risk adjustment methodology and documentation expectations
  • Adjustments to Medicare Advantage Star Ratings measures and quality programs
  • Updates related to plan oversight and beneficiary protections
  • Technical adjustments to payment calculations and program requirements

While rate updates often receive the most attention, the operational changes embedded within the rule frequently have a deeper long-term impact on how Medicare Advantage organizations manage risk adjustment, quality performance, and regulatory compliance.

Q6. Why do risk adjustment and Medicare Advantage Star Ratings increasingly influence each other?

Historically, many Medicare Advantage organizations managed risk adjustment and Medicare Advantage Star Ratings as largely separate initiatives. Risk adjustment programs focused on documentation accuracy and RAF capture, while quality teams focused on preventive care, medication adherence, and outcome measures.

Recent regulatory direction suggests increasing alignment between these areas. When documented risk profiles do not align with longitudinal care patterns—such as monitoring, treatment adherence, or care coordination—those inconsistencies may surface not only in audit exposure but also in quality performance and utilization patterns.

As a result, many organizations are beginning to approach risk documentation and care delivery as part of a more integrated operational strategy.

About Bloom Value

Bloom Value helps healthcare organizations strengthen risk adjustment performance through AI-driven analytics and documentation intelligence. By identifying coding gaps, improving documentation integrity, and aligning risk signals with clinical activity, Bloom enables Medicare Advantage plans to navigate evolving regulatory expectations with greater confidence, while optimizing your revenue and operational efficiency.